tiprankstipranks
Trending News
More News >
Tenet Healthcare (DE:THC1)
FRANKFURT:THC1
Germany Market

Tenet Healthcare (THC1) Earnings Dates, Call Summary & Reports

Compare
3 Followers

Earnings Data

Report Date
Jul 17, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
2.47
Last Year’s EPS
2.05
Same Quarter Last Year
Based on 17 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Apr 29, 2025
|
% Change Since: 25.47%
|
Next Earnings Date:Jul 17, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with significant growth in revenue, EBITDA, and improved margins across segments. The company's strategic investments and capital management were emphasized, but there was caution due to healthcare policy uncertainties. Overall, the positive aspects of financial performance outweighed the cautious outlook related to policy uncertainties.
Company Guidance
During the first quarter of 2025, Tenet Healthcare Corporation reported robust financial performance with net operating revenues of $5.2 billion and a consolidated adjusted EBITDA of $1.163 billion, marking a 14% growth compared to the previous year. The company achieved an adjusted EBITDA margin of 22.3%, representing a 320 basis point improvement over the prior year. Notably, USPI's adjusted EBITDA increased by 16% to $56 million, and the hospital segment's adjusted EBITDA rose by 12% to $707 million, with same-store hospital admissions up by 4.4%. Despite this strong start, Tenet did not adjust its full-year guidance, acknowledging the early stage of the fiscal year. The company highlighted its strategic focus on capital deployment, including a $250 million annual investment in ambulatory space M&A and the addition of six new centers. Furthermore, Tenet repurchased 2.6 million shares for $348 million, maintaining a net debt to EBITDA minus NCI ratio of 3.1 as of March 31, 2025. The company emphasized its commitment to growth, operational excellence, and managing healthcare policy uncertainties while enhancing shareholder value through effective capital allocation.
Strong Revenue and EBITDA Growth
First quarter 2025 net operating revenues were $5.2 billion with consolidated adjusted EBITDA of $1.163 billion, representing a 14% growth over 2024.
Improved EBITDA Margins
Adjusted EBITDA margin improved by 320 basis points to 22.3% in the first quarter of 2025.
USPI Segment Performance
USPI delivered $56 million in adjusted EBITDA, a 16% growth, with a 6.8% increase in same facility system-wide revenues.
Hospital Segment Growth
Adjusted EBITDA for the hospital segment grew 12% to $707 million, with same store hospital admissions up 4.4% and revenue per adjusted admission up 2.8%.
Capital Deployment and Balance Sheet Management
Net debt to EBITDA minus NCI ratio was 3.1, with plans to invest $250 million annually in ambulatory M&A and a $348 million share repurchase.
Significant Free Cash Flow Generation
Generated $642 million of free cash flow in the first quarter, with $3 billion in cash on hand and no significant debt maturities until 2027.
---

Tenet Healthcare (DE:THC1) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:THC1 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 17, 20252025 (Q2)
2.47 / -
2.045
Apr 29, 20252025 (Q1)
2.77 / 3.86
2.85135.40% (+1.01)
Feb 12, 20252024 (Q4)
2.61 / 3.05
2.37328.36% (+0.67)
Oct 29, 20242024 (Q3)
2.09 / 2.59
1.275103.47% (+1.32)
Jul 24, 20242024 (Q2)
1.69 / 2.05
1.27560.42% (+0.77)
Apr 30, 20242024 (Q1)
1.29 / 2.85
1.257126.76% (+1.59)
Feb 08, 20242023 (Q4)
1.42 / 2.37
1.73536.73% (+0.64)
Oct 30, 20232023 (Q3)
1.06 / 1.28
1.2750.00% (0.00)
Jul 31, 20232023 (Q2)
1.11 / 1.28
1.328-4.00% (-0.05)
Apr 25, 20232023 (Q1)
1.02 / 1.26
1.709-26.42% (-0.45)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

DE:THC1 Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 29, 2025€106.00€108.00+1.89%
Feb 12, 2025€134.00€124.00-7.46%
Oct 29, 2024€132.00€129.00-2.27%
Jul 24, 2024€123.00€127.00+3.25%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Tenet Healthcare (DE:THC1) report earnings?
Tenet Healthcare (DE:THC1) is schdueled to report earning on Jul 17, 2025, TBA Not Confirmed.
    What is Tenet Healthcare (DE:THC1) earnings time?
    Tenet Healthcare (DE:THC1) earnings time is at Jul 17, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Tenet Healthcare stock?
          The P/E ratio of Tenet Healthcare is N/A.
            What is DE:THC1 EPS forecast?
            DE:THC1 EPS forecast for the fiscal quarter 2025 (Q2) is 2.47.
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis